Page 116 - FBL AR 2019-20
P. 116

Fermenta Biotech Limited
           Annual Report 2019-20



          Standalone Balance Sheet as at March 31, 2020
                                                                                                      ( H in Lakhs )
                                                                             Notes  March 31, 2020  March 31, 2019
                                                                                                  (Refer note 1.2)
          ASSETS
          Non-current assets
            (a) Property, plant and equipment                                 3           10,395.19     9,722.81
            (b) Capital work-in-progress                                                   6,707.51     2,072.16
            (c) Right-of-use assets                                           4            1,615.70         -
            (d) Investment property                                           5            7,075.00     7,330.56
            (e) Goodwill                                                                   411.65        411.65
            (f) Other Intangible assets                                       6            184.06        230.20
            (g) Intangible assets under development                                        369.38         85.99
            (h) Investments
              i)   Investments in subsidiaries                                7A            85.30         65.97
              ii)   Investments in an associate                               7B               -            -
            (i) Financial assets
              (i)   Investments                                               7C            25.60         61.78
              (ii)   Share application money                                  8                -         597.00
              (iii)  Loans                                                    9             25.00         25.32
              (iv)  Other financial assets                                    10           405.68        462.75
            (j) Deferred tax assets (net)                                     46C          3,809.95     1,931.11
            (k) Non-current tax assets (net)                                  11           906.59        332.21
            (l) Other non-current assets                                      12           698.88       2,241.39
            Total non-current assets                                                      32,715.49    25,570.90
          Current assets
            (a) Inventories                                                   13          11,354.43     8,766.53
            (b) Financial assets
              (i)   Investments                                               14               -         114.79
              (ii)   Trade receivables                                        15           7,744.28     6,560.18
              (iii)  Cash and cash equivalents                                16           677.41       4,036.27
              (iv)  Bank balances other than (iii) above                      17           2,559.54     5,036.92
              (v)   Loans                                                     18           2,130.00     1,180.26
              (vi)  Other financial assets                                    19           1,294.12      259.50
            (c) Other current assets                                          20           2,485.79     3,571.73
            Total current assets                                                          28,245.57    29,526.18
            TOTAL ASSETS                                                                  60,961.06    55,097.08
          EQUITY AND LIABILITIES
          Equity
            (a) Equity share capital                                          21           1,442.37      458.64
            (b) Equity shares pending issuance                                                 -          22.15
            (c) Other equity                                                  22          29,817.82    24,467.88
            Total equity                                                                  31,260.19    24,948.67
          Liabilities
          Non-current liabilities
            (a) Financial liabilities
              (i)   Borrowings                                                23          10,178.67    13,520.93
              (ii)   Lease liabilities                                        44           450.96           -
              (iii)  Other financial liabilities                              24            59.44        185.18
            (b) Provisions                                                    25           405.83        630.94
            (c) Other non-current liabilities                                 26            54.93        133.41
            Total non-current liabilities                                                 11,149.83    14,470.46
          Current liabilities
            (a) Financial liabilities
              (i)   Borrowings                                                27          10,433.30     6,021.25
              (ii)   Lease liabilities                                        44           105.19           -
              (iii)  Trade payables
                 (A)  Total outstanding dues of micro and small enterprises and;  50        98.01         97.89
                 (B)  Total outstanding dues of creditors other than micro and small enterprises  4,619.37  4,246.45
              (iv)  Other financial liabilities                               28           2,973.78     4,252.78
            (b) Other current liabilities                                     29           233.61        489.79
            (c) Provisions                                                    30            55.76         57.28
            (d) Current tax liabilities (net)                                 31            32.02        512.51
            Total current liabilities                                                     18,551.04    15,677.95
            TOTAL EQUITY AND LIABILITIES                                                  60,961.06    55,097.08
          See accompanying notes to the Standalone financial statements      1-64              -            -
          In terms of our report attached
          For DELOITTE HASKINS & SELLS LLP    For and on behalf of the Board of Directors of
          Chartered Accountants               Fermenta Biotech Limited (Formerly known as DIL Limited)

          Rajesh K. Hiranandani               Krishna Datla            Satish Varma     Prashant Nagre
          Partner                             Managing Director        Executive Director   Chief Executive Officer

                                              Sumesh Gandhi            Srikant N. Sharma
                                              Chief Financial Officer   Company Secretary
          Mumbai, August 28, 2020             Thane, August 28, 2020




          114
   111   112   113   114   115   116   117   118   119   120   121